Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for RIZATRIPTAN

Ingredient

RIZATRIPTAN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
MAXALT RPD	5MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2018-10-16	2019-03-02	64443
MAXALT RPD	5MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2023-02-23	2023-05-27	185520
MAXALT RPD	10MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2017-03-13	2017-03-16	1344
MAXALT RPD	10MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2022-08-23	2023-03-04	167630
MAXALT RPD	10MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2023-03-20	2023-04-05	187527
MYLAN-RIZATRIPTAN ODT	10MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2017-08-29	2017-09-30	20575
MYLAN-RIZATRIPTAN ODT	5MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2026-01-26	2026-02-10	276589
MYLAN-RIZATRIPTAN ODT	5MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2017-08-29	2017-09-30	20578
MYLAN-RIZATRIPTAN ODT	10MG	TABLET (ORALLY DISINTEGRATING)	Actual shortage	2026-01-26	2026-03-09	276592
NAT-RIZATRIPTAN ODT	10MG	TABLET (ORALLY DISINTEGRATING)	Actual shortage	2025-04-04	2025-07-03	254190

Previous
1
2
3
4
5
6
…
9
Next

Showing 31 to 40 of 85

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
MINT-RIZATRIPTAN ODT	10MG	TABLET (ORALLY DISINTEGRATING)	Discontinued	2017-06-21	2017-07-01	13553

Showing 11 to 11 of 11